Emergent BioSolutions Inc

EBSNYSE · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

51.3M

on 2026-06-30, from 52.4M on 2024-03-31 10-Q ↗

Newest

$250.0M

S-3 of 2025-08-07. None sold under it to 2026-10-05. S-3 ↗

10 of its filings are not read yet.

Warrants

2.50M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

$139.7M

Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗

Raised: 15 of its filings are not read yet.